• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平治疗强直性肌营养不良症的肌强直

Nifedipine in the treatment of myotonia in myotonic dystrophy.

作者信息

Grant R, Sutton D L, Behan P O, Ballantyne J P

出版信息

J Neurol Neurosurg Psychiatry. 1987 Feb;50(2):199-206. doi: 10.1136/jnnp.50.2.199.

DOI:10.1136/jnnp.50.2.199
PMID:3553433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1031492/
Abstract

Abnormal calcium transport may be implicated in the membrane defect in myotonic dystrophy. A single blind crossover trial of placebo (t.i.d.), nifedipine 10 mg (t.i.d.) and nifedipine 20 mg (t.i.d.), was performed in 10 patients with myotonic dystrophy. The severity of myotonia was assessed by measuring finger extension time after maximum voluntary finger flexion. A significant improvement in myotonia, after nifedipine, was recorded by this technique and supported by a subjective improvement in 50% of patients and clinical improvement of greater than 20% in five patients. Initial grip strength and muscle fatiguability measured by grip strength ergometry were not significantly altered.

摘要

钙转运异常可能与强直性肌营养不良的膜缺陷有关。对10例强直性肌营养不良患者进行了一项单盲交叉试验,分别给予安慰剂(每日三次)、硝苯地平10毫克(每日三次)和硝苯地平20毫克(每日三次)。通过测量最大自主手指屈曲后手指伸展时间来评估肌强直的严重程度。用该技术记录到硝苯地平治疗后肌强直有显著改善,50%的患者主观感觉改善,5例患者临床改善超过20%。通过握力测力计测量的初始握力和肌肉疲劳性没有明显改变。

相似文献

1
Nifedipine in the treatment of myotonia in myotonic dystrophy.硝苯地平治疗强直性肌营养不良症的肌强直
J Neurol Neurosurg Psychiatry. 1987 Feb;50(2):199-206. doi: 10.1136/jnnp.50.2.199.
2
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.美西律是 1 型肌强直性营养不良的有效抗肌阵挛治疗药物。
Neurology. 2010 May 4;74(18):1441-8. doi: 10.1212/WNL.0b013e3181dc1a3a.
3
Drug treatment for myotonia.肌强直的药物治疗。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004762. doi: 10.1002/14651858.CD004762.pub2.
4
Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.使用市售测力计对 1 型和 2 型肌强直性营养不良进行定量肌强直评估。
Muscle Nerve. 2019 Apr;59(4):431-435. doi: 10.1002/mus.26401. Epub 2019 Jan 9.
5
The Association of methylprednisolone dosing to cessation of myotonia in a patient with myotonic dystrophy type 1.1 型肌强直性营养不良患者甲基泼尼松龙剂量与肌强直停止的关系。
Neuromuscul Disord. 2020 May;30(5):427-430. doi: 10.1016/j.nmd.2020.03.004. Epub 2020 Mar 18.
6
Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).计算机化握力肌测量法能够可靠地测量强直性肌营养不良症(DM1)中的肌强直和肌肉力量。
Muscle Nerve. 2007 Sep;36(3):320-8. doi: 10.1002/mus.20822.
7
Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.强直性肌营养不良患者握力、肌强直及疲劳的定量检测
J Neurol Sci. 1983 Jul;60(1):157-68. doi: 10.1016/0022-510x(83)90135-1.
8
Clinical and electrophysiological observations in patients with myotonic muscle disease and the therapeutic effect of N-propyl-ajmalin.
J Neurol. 1975 Sep 1;210(2):99-110. doi: 10.1007/BF00316381.
9
A comparative study of disopyramide and procainamide in the treatment of myotonia in myotonic dystrophy.丙吡胺与普鲁卡因胺治疗强直性肌营养不良症中肌强直的对比研究。
J Neurol Neurosurg Psychiatry. 1982 May;45(5):461-3. doi: 10.1136/jnnp.45.5.461.
10
Treatment of myotonia with antiarrhythmic drugs.用抗心律失常药物治疗肌强直。
Acta Neurol Scand. 1992 Oct;86(4):371-5. doi: 10.1111/j.1600-0404.1992.tb05103.x.

引用本文的文献

1
Drug treatment for myotonia.肌强直的药物治疗。
Cochrane Database Syst Rev. 2025 Apr 8;4(4):CD004762. doi: 10.1002/14651858.CD004762.pub3.
2
Effectiveness and safety of mexiletine versus placebo in patients with myotonia: a systematic review and meta-analysis.美西律对比安慰剂治疗肌强直患者的有效性和安全性:系统评价和荟萃分析。
Neurol Sci. 2024 Aug;45(8):3989-4001. doi: 10.1007/s10072-024-07412-z. Epub 2024 Feb 26.
3
Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model.维拉帕米减轻肌强直性营养不良小鼠模型中的氯离子和钙离子双通道病。

本文引用的文献

1
Procaine amide in the treatment of myotonia.普鲁卡因胺治疗肌强直。
Brain. 1955;78(1):81-91. doi: 10.1093/brain/78.1.81.
2
THE HEART IN MYOTONIC DISEASE.
Acta Med Scand. 1964 Oct;176:479-91. doi: 10.1111/j.0954-6820.1964.tb00953.x.
3
The treatment of myotonia: a controlled clinical trial.肌强直的治疗:一项对照临床试验。
Brain. 1959 Mar;82(1):81-91. doi: 10.1093/brain/82.1.81.
J Clin Invest. 2024 Jan 2;134(1):e173576. doi: 10.1172/JCI173576.
4
Muscle Ultrasound Shear Wave Elastography as a Non-Invasive Biomarker in Myotonia.肌肉超声剪切波弹性成像作为强直性肌营养不良的一种非侵入性生物标志物
Diagnostics (Basel). 2021 Jan 23;11(2):163. doi: 10.3390/diagnostics11020163.
5
Guidelines on clinical presentation and management of nondystrophic myotonias.非营养不良性肌强直症的临床特征和处理指南。
Muscle Nerve. 2020 Oct;62(4):430-444. doi: 10.1002/mus.26887. Epub 2020 May 27.
6
The Change of Grip Strength in a Patient with Congenital Myotonic Dystrophy Over a 4-year Period.一名先天性肌强直性营养不良患者握力在4年期间的变化
J Jpn Phys Ther Assoc. 2008;11(1):23-7. doi: 10.1298/jjpta.11.23.
7
Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.美西律是 1 型肌强直性营养不良的有效抗肌阵挛治疗药物。
Neurology. 2010 May 4;74(18):1441-8. doi: 10.1212/WNL.0b013e3181dc1a3a.
8
Drug treatment for myotonia.肌强直的药物治疗。
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004762. doi: 10.1002/14651858.CD004762.pub2.
9
Nifedipine in the treatment of myotonia.硝苯地平治疗肌强直
J Neurol Neurosurg Psychiatry. 1988 Feb;51(2):316-8. doi: 10.1136/jnnp.51.2.316-a.
4
The treatment of dystrophia myotonica with A.C.T.H.用促肾上腺皮质激素治疗强直性肌营养不良症
J Neurol Neurosurg Psychiatry. 1954 Feb;17(1):83-6. doi: 10.1136/jnnp.17.1.83.
5
Metabolic heat production in isometric ischaemic contractions of human adductor pollicis.人拇收肌等长缺血性收缩时的代谢产热
Clin Physiol. 1982 Dec;2(6):499-512. doi: 10.1111/j.1475-097x.1982.tb00056.x.
6
The effect of temperature, ischaemia and contractile activity on the relaxation rate of human muscle.温度、局部缺血及收缩活动对人体肌肉舒张速率的影响。
Clin Physiol. 1982 Dec;2(6):485-97. doi: 10.1111/j.1475-097x.1982.tb00055.x.
7
Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.强直性肌营养不良患者握力、肌强直及疲劳的定量检测
J Neurol Sci. 1983 Jul;60(1):157-68. doi: 10.1016/0022-510x(83)90135-1.
8
Treatment of myotonic dystrophy with tricyclics.
Muscle Nerve. 1983 Mar-Apr;6(3):233-4. doi: 10.1002/mus.880060311.
9
The quantification of myotonia. A problem in the evaluation of new antimyotonic drugs.
J Neurol Sci. 1983 May;59(2):167-73. doi: 10.1016/0022-510x(83)90035-7.
10
In vivo effects of three calcium blockers on chickens with inherited muscular dystrophy.
Exp Neurol. 1984 Jun;84(3):512-23. doi: 10.1016/0014-4886(84)90200-0.